Cramer Joyce A., Glassman Marc, Rienzi Vincent
Yale University School of Medicine, 06516-2770, New Haven, CT, USA
Epilepsy Behav. 2002 Aug;3(4):338-342. doi: 10.1016/s1525-5050(02)00037-9.
Predictors and consequences of inadequate compliance with seizure medications were assessed using a 10-item postal survey. Dose omissions were reported by 71% of the 661 respondents (2+/-2 doses of seizure medications), with 45% of patients reporting a seizure after a missed dose, at some time during treatment. Dose omission was more likely with longer use of seizure medications (more than 5 years, P<0.01). Having seizures after missed doses was associated with number of seizure medication doses (P=0.04) and number of seizure medication tablets/capsules (P=0.01). Odds ratios showed that each increase in dose frequency (one, two, three, or four doses daily) increased the likelihood of a seizure after a missed dose by 36%. Taking larger numbers of tablets/capsules increased the odds of having a seizure after missed doses by 43%. These data provide evidence that medication compliance remains an important issue in epilepsy treatment.
通过一项包含10个项目的邮政调查,对癫痫药物依从性不足的预测因素及后果进行了评估。661名受访者(服用2±2剂癫痫药物)中有71%报告有漏服剂量的情况,45%的患者报告在治疗期间的某个时候漏服一剂后出现了癫痫发作。癫痫药物使用时间越长(超过5年),漏服剂量的可能性越大(P<0.01)。漏服剂量后出现癫痫发作与癫痫药物剂量数量(P=0.04)和癫痫药物片剂/胶囊数量(P=0.01)有关。比值比显示,剂量频率每增加一次(每日一、二、三或四剂),漏服剂量后癫痫发作的可能性就增加36%。服用更多数量的片剂/胶囊会使漏服剂量后癫痫发作的几率增加43%。这些数据证明,药物依从性在癫痫治疗中仍然是一个重要问题。